Fennec Pharmaceuticals (FENC) Shareholder's Equity Growth (3y) (2013 - 2025)
Fennec Pharmaceuticals (FENC) Shareholder's Equity Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Fennec Pharmaceuticals |
257.19 Mn |
220.41 Mn |
7.67 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
150.97% |
| Sep 30, 2025 |
-53.31% |
| Jun 30, 2025 |
-42.17% |
| Mar 31, 2025 |
-35.17% |
| Dec 31, 2024 |
-33.37% |
| Sep 30, 2024 |
-31.46% |
| Jun 30, 2024 |
-27.26% |
| Mar 31, 2024 |
-50.55% |
| Dec 31, 2023 |
-33.88% |
| Sep 30, 2023 |
-32.72% |
| Jun 30, 2023 |
-31.41% |
| Mar 31, 2023 |
-42.07% |
| Dec 31, 2022 |
-30.38% |
| Sep 30, 2022 |
-42.84% |
| Jun 30, 2022 |
-19.67% |
| Mar 31, 2022 |
-13.28% |
| Dec 31, 2021 |
-9.55% |
| Sep 30, 2021 |
-5.96% |
| Jun 30, 2021 |
-3.58% |
| Mar 31, 2021 |
-0.96% |
